ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
  • Trust Score
Company
  • About
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint745,629 companies indexed · Last updated: today
DirectoryIndustryPharmaceutical IndustryGenevaSTALICLA SA
STALICLA SA Logo
Verified· 3 sourcesTrust Score
Summary

About the company

STALICLA SA is a biopharmaceutical company developing precision medicines and clinical programs for neurodevelopmental and neuropsychiatric disorders. It uses the DEPI neuro-precision platform, combining multi-omics, patient data and AI to identify subgroups and match patients with drug treatments.

AI-generated
Offering

Products & services

Industry:Pharmaceutical Industry
✓ Offered6
Precision medicine drug development
Precision medicine drug development for neurodevelopmental and neuropsychiatric disorders, with patient-specific subgroup identification, biomarker-based analysis and clinical development of drug candidates.
DEPI Platform
DEPI platform for patient-drug precision matching, multi-omics analysis, patient stratification, responder subgroup identification and prioritization of drug candidates for targeted therapies.
Clinical development of STP1
Clinical development of STP1 as a fixed combination of ibudilast and bumetanide for an ASD subgroup, including completion of Phase 1b and Phase 2 follow-on development.
Clinical development of STP2
Clinical development of STP2 (SFX-01), a stabilized synthetic sulforaphane formulation for neurodevelopmental disorders and an ASD subgroup, with Phase 1 data and preparation for Phase 2.
Clinical development of STP7
Clinical development of STP7 (Mavoglurant) for an ASD subgroup and for cocaine use disorder, with Phase 2 experience and planned or ongoing additional studies.
Patient recruitment for clinical trials
Patient recruitment for clinical trials in neurodevelopmental and substance-use disorders, with a subgroup focus, clinical data use and a precision-medicine-oriented enrichment strategy.
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
4.1/5

STALICLA SA

Trust & reputation

ranQ Trust Score of STALICLA SA: 4.1 out of 5.0

Trust Score4.1/ 5.0

High

x

Data basis 58% · As of October 2026

Without public customer reviews the score stays capped.

STALICLA SA has no value in the Reputation area of the ranQ Trust Score because no data is available. The area carries 42% of the weighting and drops out of the calculation for this profile; it does not lower the score, only the reported data basis.
x
CriterionValueWeight
  • Review quality: No data point — the criterion is taken out of the weighting and does not lower the score.—24%
  • Review volume: No data point — the criterion is taken out of the weighting and does not lower the score.—10%
  • Review recency: No data point — the criterion is taken out of the weighting and does not lower the score.—8%
STALICLA SA scores 82.0 out of 100 points in the Substance area of the ranQ Trust Score. This area carries 28% of the weighting.
x
CriterionValueWeight
  • Establishment: Years since founding or brand launch, logarithmic. The maximum is reached at 15 years.83.012%
  • Company size: The headcount band, researched by ranQ or stated by the company. It is scored in steps rather than by head count, because the data only provides bands.70.07%
STALICLA SA scores 85.0 out of 100 points in the Identity area of the ranQ Trust Score. This area carries 22% of the weighting.
x
CriterionValueWeight
  • Verification: Official register entry (commercial register with UID or professional-body record, 55 points), confirmed domain (20 points) and confirmed ranQ profile (up to 25 points, depending on completeness).85.022%
STALICLA SA scores 58.4 out of 100 points in the Visibility area of the ranQ Trust Score. This area carries 8% of the weighting.
x
CriterionValueWeight
  • Website authority: Ahrefs' Domain Rating measures, on a scale of 0 to 100, how strongly a website is linked from other websites. For Swiss SMEs the range up to 40 is typical; the maximum is reached at 35.100.04%
  • Media authority: Quality and number of editorial mentions, weighted by the importance of the source, plus the recency of the latest high-quality mention.16.74%
Qualifications+0.00

STALICLA SA reaches a ranQ Trust Score of 4.1 out of 5.0 — rated «High». No public customer reviews are available for this provider; the rating is based on the remaining criteria. The data basis is 58%, so the score is backed by part of the criteria. As of October 2026.

The Trust Score cannot be bought and is calculated from publicly verifiable data.

Press

Media

July 2, 2025Media
Addex Therapeutics leads Stalicla’s CHF 2 million round
startupticker.ch

Knowledge

No knowledge articles yet

Once STALICLA SA has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

STALICLA SA in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank STALICLA SA by reviews, experience and specialisations.

Is this your company?

Claim the company profile of STALICLA SA to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Avenue de Sécheron 15
1202 Geneva

At a glance

Legal form
Corporation
UID
CHE-421.223.128
Founded
2017 · 9 years
Last commercial register change
September 4, 2026
Employees
11 to 20
Legal form: Graded by liability and disclosure. The weight is kept small: a sole proprietorship is not a dubious company, it is just liable differently.
100.0
6%
  • Branch offices: Branch offices linked in the commercial register. Having none is normal and costs no points.70.03%
    • Full methodology

    Similar companies

    IS
    iOnctura SA
    Geneva
    AT
    Atopia Therapeutics SA
    Geneva
    RT
    Relief Therapeutics International SA
    Geneva
    AS
    argenx Switzerland SA
    Châtelaine
    AP
    Addex Pharma SA
    Plan-Les-Ouates
    IT
    IREMIS Therapeutics SA
    Anières
    SD
    SOLID Drug Development SA
    Geneva
    IH
    IQONE HEALTHCARE SWITZERLAND SA
    Versoix